Nonalcoholic fatty liver disease (NAFLD) is a common, multifactorial, and poorly understood
liver disease whose incidence is globally rising. During the past decade, several lines of …

Introduction: Nonalcoholic fatty liver disease (NAFLD) is one of the most common and
increasing liver diseases worldwide with a prevalence of 20–33%. NAFLD may progress to …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder worldwide. It
comprises a spectrum of conditions that range from steatosis to non-alcoholic …

NAFLD is currently the main cause of chronic liver disease in developed countries, and the
number of NAFLD patients is growing worldwide. NAFLD often has similar symptoms to …

In the past two decades, the rapid increase in the incidence of metabolic diseases, including
obesity, diabetes, dyslipidemia, non-alcoholic fatty liver disease, hypertension, and …

The prevalence of metabolic diseases, including, most notably, type 2 diabetes mellitus, is
increasing worldwide at an alarming rate. Although many factors have been implicated in …

Dietary patterns and corresponding gut microbiota profiles are associated with various
health conditions. A diet rich in polyphenols, primarily plant-based, has been shown to …

The human digestive system harbors a diverse and complex community of microorganisms
that work in a symbiotic fashion with the host, contributing to metabolism, immune response …

Non-alcoholic fatty liver disease (NAFLD) is regarded as a pandemic that affects about a
quarter of the global population. Recently, host-gut microbiota metabolic interactions have …

Metabolic dysfunction‐associated fatty liver disease (MAFLD) is a complex disease
involving alterations in multiple biological processes regulated by the interactions between …